Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Dec 19, 2024 6:14pm
25 Views
Post# 36371227

RE:RE:Using a single 4-chamber image clip, Us2.ai !

RE:RE:Using a single 4-chamber image clip, Us2.ai !Sory 
Interesting on Us2.ai, AI-echo to diagnose Cardiac Amyloidosis: a multi-centre international development and validation study Dec 18, 2024 https://us2.ai/ai-echo-to-diagnose-cardiac-amyloidosis-a-multi-centre-international-development-and-validation-study/
& Remember Interesting on Linkedin Catch Us2.ai on the Road! EuroEcho2024 in Berlin! Us2.ai will be attending #EuroEcho2024 in Berlin from 11-13 December! Find us at Booth B2 Join us for live scanning and an exclusive experience of our cutting-edge AI technology that’s redefining echocardiography.
Remember on website Ascend https://ascendcv.com/ Click on integrations & see Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include: Us2.ai
- Benefit from the the industry’s most sophisticated integration of Us2.ai.

-Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report 
Save time with single-click navigation to the automated measurement source frame 
1-click sync to automated measurement frame
Distinct review processes for FDA-cleared versus investigational measurements, enhancing compliance and clarity 
Automatic grouping of Us2.ai measurements accelerates the measurement review process 
Visual notification of user edits performed on Us2.ai measurements promotes transparency and traceability 
Engineered for seamless integration: Gen3Echo was designed with commitment to openness, seamlessly integrating with AI, ML, and advanced visualization software to foster innovation and collaboration. 
-Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients.
-Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.
<< Previous
Bullboard Posts
Next >>